相关实验视频

Updated: Jun 21, 2025

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

膀癌瘤发生的分子基础和开发治疗点的新概念

Rana M Abdeltwab¹, Elaria Yacoub¹, Ahmed H Rashad¹

¹Department of Clinical Oncology, Cairo University, Cairo, Egypt.

Bladder cancer (Amsterdam, Netherlands)

|July 12, 2024

概括

了解泌尿腺癌 (UC) 需要探索其突变性起源. 本综述涵盖UC病因学和有前途的向疗法,强调需要UC特异性生物标志物进行有效治疗.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
分子生物学分子生物学

背景情况:

晚期泌尿腺癌 (UC) 是具有不完全理解的突变性过程的侵袭性.
向疗法至关重要,但从研究到临床应用的发展缓慢.

研究的目的:

审查尿癌 (UC) 基因组学和候选向治疗的最新进展.
阐明UC瘤发生的病因和分子基础.

主要方法:

对临床前和临床研究进行了全面的文献搜索.
关于UC基因组学和向治疗的最新更新的审查.

主要成果:

UC瘤发生涉及吸烟,致癌物,遗传和APOBEC3编辑等因素.
UC的突变格局是由这些因素塑造的.
有前途的向疗法包括FGFR,DNA损伤修复和HER2通路.

结论:

针对UC的特定生物标志物对于有效的向治疗选择至关重要.
对UC生物学和进化进行进一步的研究至关重要.
针对性治疗的通用测试对于UC治疗是不够的.

关键词:

在 DDR 路径上.泌尿器癌泌尿器癌是什么?生物标志物生物标志物分子目标是分子目标.瘤发生的起源

更多相关视频

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...